Skip to main content
. 2020 Jan 3;12(1):41. doi: 10.3390/pharmaceutics12010041

Table 2.

Percentages of bound Sunitinib (SUT) and Semaxanib (SEM) by imprinted (MIP) and non-imprinted (NIP) particles and α and ε values for different Ci. Data are shown as means ± S.D.

Ci (mol/L) Bound SUT (%) Bound SEM (%) α SUT α SEM ɛ
MIP NIP MIP NIP
0.00001 47.2 ± 0.6 34.5 ± 0.5 12.5 ± 0.6 11.5 ± 0.4 1.37 1.09 3.77
0.00002 51.5 ± 0.7 42.5 ± 0.7 14.1 ± 0.6 11.8 ± 0.7 1.21 1.19 3.66
0.00004 56.3 ± 0.4 40.3 ± 0.3 11.8 ± 0.5 10.1 ± 0.6 1.40 1.16 4.79
0.00006 58.3 ± 0.5 41.7 ± 0.5 7.9 ± 0.8 6.6 ± 0.4 1.40 1.20 7.37
0.00008 66.9 ± 0.6 46.3 ± 0.4 26.9 ± 0.4 22.5 ± 0.8 1.45 1.19 2.49
0.0001 71.0 ± 0.7 47.9 ± 0.6 42.1 ± 0.5 37.9 ± 0.5 1.48 1.11 1.69
0.0002 75.0 ± 0.4 48.3 ± 0.6 50.2 ± 0.7 47.3 ± 0.5 1.55 1.06 1.49
0.0004 80.3 ± 0.8 50.0 ± 0.3 52.8 ± 0.5 51.3 ± 0.7 1.61 1.03 1.52
0.0006 77.5 ± 0.5 47.5 ± 0.8 50.8 ± 0.6 48.3 ± 0.3 1.63 1.05 1.52
0.0008 68.8 ± 0.3 46.3 ± 0.5 42.5 ± 0.4 40.1 ± 0.7 1.49 1.06 1.62